Summary & Overview
HCPCS S4011: In Vitro Fertilization, Oocyte Fertilization and Embryo Culture
HCPCS Level II code S4011 denotes in vitro fertilization (IVF) laboratory procedures including identification and incubation of mature oocytes, fertilization with sperm, embryo incubation, and visualization for development assessment. This code captures core embryology services that are central to assisted reproductive technology and fertility treatment pathways. Nationally, IVF-related services have significant clinical and financial implications due to their complexity, resource intensity, and growing utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of how S4011 is defined clinically, typical sites of service, and common billing considerations. The publication also provides benchmarks and payer coverage patterns where available, summarizes relevant policy trends affecting IVF laboratory services, and outlines clinical context important for coding and billing workflows.
This summary is intended for health policy analysts, billing professionals, and clinical administrators seeking a concise reference on HCPCS Level II code S4011, its role in fertility care, and the payer landscape for IVF laboratory services. Data not available in the input is identified as such in appropriate sections.
Billing Code Overview
HCPCS Level II code S4011 describes in vitro fertilization, including identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization to determine embryo development. This code represents the laboratory and embryology processes central to assisted reproductive technology.
-
Service type: Laboratory-based assisted reproductive procedure involving oocyte handling, fertilization, and embryo culture
-
Typical site of service: Fertility clinic or in vitro fertilization laboratory associated with an outpatient reproductive medicine center
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman with a 3-year history of infertility and a diagnosis of diminished ovarian reserve presents to a reproductive endocrinology clinic for in vitro fertilization. The clinical workflow begins with patient counseling, ovarian stimulation with serial monitoring (ultrasound and serum estradiol), transvaginal oocyte retrieval under monitored anesthesia, laboratory identification and incubation of mature oocytes, fertilization with partner or donor sperm, embryo culture and monitoring, and subsequent embryo visualization to assess development prior to transfer or cryopreservation. Typical site of service is an outpatient fertility center with an on-site embryology laboratory; some components (monitoring, retrieval) occur in the clinic procedural suite or ambulatory surgery center. The procedure coded by S4011 covers the laboratory processes from oocyte identification and incubation through fertilization and embryo development assessment. Typical patients include those with tubal factor infertility, male factor infertility, ovulatory dysfunction, endometriosis, or unexplained infertility. Clinical documentation should link diagnostic indications, stimulation protocol, retrieval date/time, laboratory procedures performed, embryo development notes, and disposition (transfer, freeze, discard).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when IVF laboratory work required substantially greater effort or complexity than typical (documented and supported). |